Cite
HARVARD Citation
Liefferinckx, C. et al. (2019). Impact of first‐line infliximab on the pharmacokinetics of second‐line vedolizumab in inflammatory bowel diseases. United European Gastroenterology journal. 7 (6), pp. 750-758. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liefferinckx, C. et al. (2019). Impact of first‐line infliximab on the pharmacokinetics of second‐line vedolizumab in inflammatory bowel diseases. United European Gastroenterology journal. 7 (6), pp. 750-758. [Online].